General considerations of immunosuppressive therapies--efficacy versus toxicity.
Helderman
J H
JH
Vanderbilt Transplant Center and The Nephrology Division, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2372, USA. hal.helderman@mcmail.vanderbilt.edu
D017326:Clinical Trials, Phase III as Topic; D005767:Gastrointestinal Diseases / Q000139:chemically induced*; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid